Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTI7421)

• DTT Name: Platelet-derived growth factor receptor beta (PDGFRB) DTT Info
• Gene Name: PDGFRB

Molecule-Related Drug & Molecule List

3 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Becaplermin	DM1R5X4	Diabetic complication	5A2Y	Approved	[1]
Romiplostim	DM3U7SZ	Thrombocytopenia	3B64	Approved	[2]
Sorafenib	DMS8IFC	Adenocarcinoma	2D40	Approved	[3]

6 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
E-3810	DM42PFT	Solid tumour/cancer	2A00-2F9Z	Phase 3	[4]
Famitinib	DMSFWT7	Solid tumour/cancer	2A00-2F9Z	Phase 2	[5]
XL-820	DMMHX9K	Solid tumour/cancer	2A00-2F9Z	Phase 2	[6]
MK-2461	DM21WBH	Alzheimer disease	8A20	Phase 1/2	[7]
SNN-0031	DM2X3BR	Brain injury	NA07.Z	Phase 1/2	[8]
TAK-593	DMNFZOT	Solid tumour/cancer	2A00-2F9Z	Phase 1	[9]

4 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID25656651-Compound-21a	DMCKAON	N. A.	N. A.	Patented	[10]
PMID25656651-Compound-21b	DMVABXI	N. A.	N. A.	Patented	[10]
PMID28460551-Compound-2	DM4DOUB	N. A.	N. A.	Patented	[11]
Pyridine derivative 18	DMBZMYT	N. A.	N. A.	Patented	[12]

5 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
CDP-860	DMEI0LJ	Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 2	[13]
SRI-62-834	DMRKE9G	Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 2	[14]
CEP-2563	DMH1PQ0	Solid tumour/cancer	2A00-2F9Z	Discontinued in Phase 1	[14]
AG1295	DMT10C2	N. A.	N. A.	Terminated	[15]
RG-13022	DMRFYOS	N. A.	N. A.	Terminated	[16]

106 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone	DM21CXZ	Discovery agent	N.A.	Investigative	[17]
(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone	DM94XJ2	Discovery agent	N.A.	Investigative	[17]
(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone	DM7KDNM	Discovery agent	N.A.	Investigative	[17]
(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine	DMNGEFS	Discovery agent	N.A.	Investigative	[18]
(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone	DMIV4BU	Discovery agent	N.A.	Investigative	[17]
(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone	DMPBNYM	Discovery agent	N.A.	Investigative	[17]
(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone	DME80RK	Discovery agent	N.A.	Investigative	[15]
1-Phenyl-1H-benzoimidazol-5-ol	DMGV6BI	Discovery agent	N.A.	Investigative	[19]
1-Phenyl-1H-benzoimidazole	DM8YPH0	Discovery agent	N.A.	Investigative	[19]
2-(1H-indazol-3-yl)-1H-benzo[d]imidazole	DM0CSH8	Discovery agent	N.A.	Investigative	[20]
3-((E)-Styryl)-quinoline	DMAO64J	Discovery agent	N.A.	Investigative	[16]
3-(1H-Indol-3-yl)-6,7-dimethoxy-quinoline	DMSGCKU	Discovery agent	N.A.	Investigative	[16]
3-(1H-Indol-3-yl)-quinoline	DMW7XN5	Discovery agent	N.A.	Investigative	[16]
3-(2-Cyclohexyl-ethyl)-6,7-dimethoxy-quinoline	DMVUK96	Discovery agent	N.A.	Investigative	[16]
3-(3,4-Dichloro-phenyl)-6,7-dimethoxy-quinoline	DMEJH13	Discovery agent	N.A.	Investigative	[16]
3-(3,4-Difluoro-phenyl)-6,7-dimethoxy-quinoline	DMX3AMB	Discovery agent	N.A.	Investigative	[16]
3-(3,4-Dimethoxy-phenyl)-6,7-dimethoxy-quinoline	DMDU10A	Discovery agent	N.A.	Investigative	[16]
3-(3-Fluoro-phenyl)-6,7-dimethoxy-quinoline	DM0ZHJQ	Discovery agent	N.A.	Investigative	[16]
3-(4-dimethylamino-benzylidenyl)-2-indolinone	DM6XC0M	Discovery agent	N.A.	Investigative	[21]
3-(4-Fluoro-phenyl)-6,7-dimethoxy-quinoline	DM0POH2	Discovery agent	N.A.	Investigative	[16]
3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenol	DM4DFUS	Discovery agent	N.A.	Investigative	[22]
3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenylamine	DMAWXV6	Discovery agent	N.A.	Investigative	[22]
3-Benzimidazol-2-ylhydroquinolin-2-one	DMQXJA1	Discovery agent	N.A.	Investigative	[23]
3-Benzyloxy-6,7-dimethoxy-quinoline	DMPG315	Discovery agent	N.A.	Investigative	[16]
3-Cyclohexylethynyl-6,7-dimethoxy-quinoline	DMCQ6J8	Discovery agent	N.A.	Investigative	[16]
3-Cyclopent-1-enyl-6,7-dimethoxy-quinoline	DM1FSZM	Discovery agent	N.A.	Investigative	[16]
3-Cyclopentyl-6,7-dimethoxy-quinoline	DMS7B6T	Discovery agent	N.A.	Investigative	[16]
3-Pyridin-3-yl-quinoline-6,7-diol	DM60Q1B	Discovery agent	N.A.	Investigative	[16]
3-Pyridin-4-yl-quinolin-7-ol	DM0SEL5	Discovery agent	N.A.	Investigative	[24]
3-Pyridin-4-yl-quinoline	DM6U074	Discovery agent	N.A.	Investigative	[24]
3-Pyridin-4-yl-quinoline-5,7-diol	DMPCT0A	Discovery agent	N.A.	Investigative	[24]
3-Thiophen-3-yl-quinoline	DM9MFZ1	Discovery agent	N.A.	Investigative	[16]
4-(2,3-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	DM6PMFJ	Discovery agent	N.A.	Investigative	[22]
4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	DMW1H6C	Discovery agent	N.A.	Investigative	[22]
4-(3,5-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	DM5279R	Discovery agent	N.A.	Investigative	[22]
4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline	DMNBLQ8	Discovery agent	N.A.	Investigative	[22]
4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline	DMK6JV7	Discovery agent	N.A.	Investigative	[22]
4-(3-Ethoxy-phenoxy)-6,7-dimethoxy-quinoline	DMOQE5W	Discovery agent	N.A.	Investigative	[22]
4-(3-Ethyl-phenoxy)-6,7-dimethoxy-quinoline	DMFM9SH	Discovery agent	N.A.	Investigative	[22]
4-(3-Fluoro-phenoxy)-6,7-dimethoxy-quinoline	DMER3D9	Discovery agent	N.A.	Investigative	[22]
4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine	DMIWT60	Discovery agent	N.A.	Investigative	[25]
4-(6,7-Dimethoxy-quinolin-3-yl)-benzoic acid	DM8A6UH	Discovery agent	N.A.	Investigative	[16]
4-(6,7-Dimethoxy-quinolin-3-yl)-phenol	DM9RNUX	Discovery agent	N.A.	Investigative	[16]
4-Benzoimidazol-1-yl-phenylamine	DM7AOGD	Discovery agent	N.A.	Investigative	[19]
5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline	DM53CLY	Discovery agent	N.A.	Investigative	[24]
5,7-Dimethoxy-3-pyridin-4-yl-quinoline	DM724JF	Discovery agent	N.A.	Investigative	[24]
5,7-Dimethoxy-3-thiophen-3-yl-quinoline	DMJAQ41	Discovery agent	N.A.	Investigative	[16]
5,7-Dimethyl-3-thiophen-3-yl-quinoline	DM3P79O	Discovery agent	N.A.	Investigative	[16]
5-(6,7-Dimethoxy-quinolin-3-yl)-1H-pyridin-2-one	DMVMBG0	Discovery agent	N.A.	Investigative	[16]
5-Methoxy-1-phenyl-1H-benzoimidazole	DMPEKWD	Discovery agent	N.A.	Investigative	[19]
6,7-Dichloro-3-thiophen-3-yl-quinoline	DMJNHSL	Discovery agent	N.A.	Investigative	[16]
6,7-Difluoro-3-thiophen-3-yl-quinoline	DMUZYXQ	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-((E)-styryl)-quinoline	DMSM0QV	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-(3-methoxy-phenyl)-quinoline	DMDENVF	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-(4-methoxy-phenyl)-quinoline	DM12DVT	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-(4-nitro-phenyl)-quinoline	DMM7NHI	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-p-tolyl-quinoline	DMM7IAK	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-phenyl-quinoline	DM516B4	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-phenylethynyl-quinoline	DMFRXDT	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-pyridin-3-yl-quinoline	DMSG1AY	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-3-pyridin-4-yl-quinoline	DMW7K5P	Discovery agent	N.A.	Investigative	[24]
6,7-Dimethoxy-3-thiophen-2-yl-quinoline	DM6WD8T	Discovery agent	N.A.	Investigative	[16]
6,7-Dimethoxy-4-(2-methoxy-phenoxy)-quinoline	DMU15YV	Discovery agent	N.A.	Investigative	[22]
6,7-Dimethoxy-4-(3-methoxy-phenoxy)-quinoline	DMPS2GX	Discovery agent	N.A.	Investigative	[22]
6,7-Dimethoxy-4-(3-nitro-phenoxy)-quinoline	DM3YSNX	Discovery agent	N.A.	Investigative	[22]
6,7-Dimethoxy-4-(4-methoxy-phenoxy)-quinoline	DMX2VFP	Discovery agent	N.A.	Investigative	[22]
6,7-Dimethoxy-4-m-tolyloxy-quinoline	DMEMGPU	Discovery agent	N.A.	Investigative	[22]
6,7-Dimethoxy-4-phenoxy-quinoline	DMBZP3I	Discovery agent	N.A.	Investigative	[22]
6-Methoxy-3-pyridin-4-yl-quinoline	DM52SDO	Discovery agent	N.A.	Investigative	[24]
6-Methoxy-3-thiophen-3-yl-quinoline	DMOYL71	Discovery agent	N.A.	Investigative	[16]
7-Chloro-3-pyridin-4-yl-quinoline	DM53A1R	Discovery agent	N.A.	Investigative	[24]
7-Fluoro-3-thiophen-3-yl-quinoline	DM0QI8V	Discovery agent	N.A.	Investigative	[16]
7-Methoxy-3-pyridin-4-yl-quinoline	DMUZIDT	Discovery agent	N.A.	Investigative	[24]
7-Methoxy-3-thiophen-3-yl-quinoline	DM9QKLC	Discovery agent	N.A.	Investigative	[16]
7-Thiophen-3-yl-[1,3]dioxolo[4,5-g]quinoline	DMMU5SO	Discovery agent	N.A.	Investigative	[16]
AGL 2043	DMM9A5N	Discovery agent	N.A.	Investigative	[26]
Benzyl-(6,7-dimethoxy-quinolin-3-yl)-amine	DMFTIMS	Discovery agent	N.A.	Investigative	[16]
Bis(5-acetoxybenzo[b]furan-2-yl)methanone	DM36VKH	Discovery agent	N.A.	Investigative	[15]
Bis(5-aminobenzo[b]furan-2-yl)methanone	DMHRGTY	Discovery agent	N.A.	Investigative	[15]
Bis(5-hydroxybenzo[b]furan-2-yl)methanone	DMGRKDP	Discovery agent	N.A.	Investigative	[15]
Bis(5-methoxybenzo[b]furan-2-yl)methanone	DM9XC6A	Discovery agent	N.A.	Investigative	[15]
Bis(6-hydroxybenzo[b]furan-2-yl)methanone	DMRGNSQ	Discovery agent	N.A.	Investigative	[15]
Bis(benzo[b]furan-2-yl)methanone	DMK2ZG4	Discovery agent	N.A.	Investigative	[15]
Bis-(5-hydroxy-1H-indol-2-yl)-methanone	DMTSEXB	Discovery agent	N.A.	Investigative	[17]
BMS-536924	DMXJB4N	Discovery agent	N.A.	Investigative	[27]
CP-673451	DMVBPRO	Discovery agent	N.A.	Investigative	[28]
Di(1H-indol-2-yl)methanone	DM3DR6J	Discovery agent	N.A.	Investigative	[17]
GTP-14564	DMW23Y9	Discovery agent	N.A.	Investigative	[29]
HKI-9924129	DM5LR2B	Gram-positive bacterial infection	1B74-1G40	Investigative	[30]
JNJ-10198409	DM9GDP5	Discovery agent	N.A.	Investigative	[18]
Ki-11502	DMLG2EA	Discovery agent	N.A.	Investigative	[31]
Ki-20227	DM9M3VC	Discovery agent	N.A.	Investigative	[32]
PD-0166326	DMD2CG9	Discovery agent	N.A.	Investigative	[30]
PD-0173952	DMSCQ9U	Discovery agent	N.A.	Investigative	[30]
PD-0173955	DMOZEW9	Discovery agent	N.A.	Investigative	[30]
PD-0173956	DM8RW92	Discovery agent	N.A.	Investigative	[30]
PD-0173958	DMZQ8YV	Discovery agent	N.A.	Investigative	[30]
PD-0179483	DMKO8LE	Discovery agent	N.A.	Investigative	[30]
PDGF receptor tyrosine kinase inhibitor III	DMORLTH	Discovery agent	N.A.	Investigative	[33]
PMID22765894C8h	DMH5RFU	Discovery agent	N.A.	Investigative	[34]
Ro-4396686	DM5DMCH	Discovery agent	N.A.	Investigative	[35]
RPR-101511	DM0HD3O	Discovery agent	N.A.	Investigative	[16]
RPR-108514A	DM37I92	Discovery agent	N.A.	Investigative	[36]
SU-11652	DMGQXN7	Discovery agent	N.A.	Investigative	[2]
TG-100435	DMIR3X2	Discovery agent	N.A.	Investigative	[37]
XB-387	DMBN7UX	Non-small-cell lung cancer	2C25.Y	Investigative	[38]

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
• [2] Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel... J Med Chem. 2003 Mar 27;46(7):1116-9.
• [3] Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling.Mol Cancer Ther.2008 Oct;7(10):3129-40.
• [4] E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models. Cancer Res. 2011 Feb 15;71(4):1396-405.
• [5] Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients. Br J Pharmacol. 2013 Apr;168(7):1687-706.
• [6] National Cancer Institute Drug Dictionary (drug id 452042).
• [7] MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor. Cancer Res. 2010 Feb 15;70(4):1524-33.
• [8] Company report (Neuronova)
• [9] Biochemical characterization of TAK-593, a novel VEGFR/PDGFR inhibitor with a two-step slow binding mechanism. Biochemistry. 2011 Feb 8;50(5):738-51.
• [10] Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412.
• [11] Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jul;27(7):753-761.
• [12] RET kinase inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jan;27(1):91-99.
• [13] Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated w... J Clin Oncol. 2005 Feb 10;23(5):973-81.
• [14] Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36.
• [15] Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. Bioorg Med Chem. 2007 Mar 1;15(5):2187-97.
• [16] A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J Med Chem. 1994 Jul 8;37(14):2129-37.
• [17] Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase. J Med Chem. 2006 Jun 1;49(11):3101-15.
• [18] (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad ant... J Med Chem. 2005 Dec 29;48(26):8163-73.
• [19] Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor. J Med Chem. 1998 Dec 31;41(27):5457-65.
• [20] Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3595-9.
• [21] Synthesis and biological activity of N(4)-phenylsubstituted-6-(2,4-dichloro phenylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines as vascular endo... Bioorg Med Chem. 2010 May 15;18(10):3575-87.
• [22] A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylation, Bioorg. Med. Chem. Lett. 7(23):2935-2940 (1997).
• [23] Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor... J Med Chem. 2009 Jan 22;52(2):278-92.
• [24] 5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a potent and selective inhibitor of human vascular beta-type platelet-derived growth factor receptor tyro... J Med Chem. 1994 Aug 19;37(17):2627-9.
• [25] Structure-activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptor. J Med Chem. 1999 Jul 1;42(13):2373-82.
• [26] Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit. Bioorg Med Chem. 2003 May 1;11(9):2007-18.
• [27] Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitum... J Med Chem. 2005 Sep 8;48(18):5639-43.
• [28] Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res. 2005 Feb 1;65(3):957-66.
• [29] Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosin... J Biol Chem. 2003 Aug 29;278(35):32892-8.
• [30] Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors. Biochem Pharmacol. 2000 Oct 1;60(7):885-98.
• [31] Identification of potent and selective inhibitors of PDGF receptor autophosphorylation. J Med Chem. 2006 Apr 6;49(7):2186-92.
• [32] A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Mol Cancer Ther. 2006 Nov;5(11):2634-43.
• [33] Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives. J Med Chem. 2003 Nov 6;46(23):4910-25.
• [34] The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett. 2012 Aug 1;22(15):4979-85.
• [35] Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis. Bioorg Med Chem Lett. 2006 Apr 1;16(7):1950-3.
• [36] The synthesis and SAR of new 4-(N-alkyl-N-phenyl)amino-6,7-dimethoxyquinazolines and 4-(N-alkyl-N-phenyl)aminopyrazolo[3,4-d]pyrimidines, inhibitors of CSF-1R tyrosine kinase activity, Bioorg. Med. Chem. Lett. 7(4):421-424 (1997).
• [37] Discovery of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine--a potent, orally active Src kinas... Bioorg Med Chem Lett. 2007 Feb 1;17(3):602-8.
• [38] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1804).